Kezar Life Sciences, Inc. 3 SEC Filings

Filed On	Filing
16 Apr 2025	Form 3: Chiang Pichi Luo, SVP, Corporate Controller Holds 2,975 shares of Common Stock
16 Apr 2025	Form 3: To Zung Phoung, SVP, Clinical Development
17 Jan 2024	Form 3: Schiller Mark C., Chief Legal Officer Holds 39,695 shares of Common Stock
15 Jul 2022	Form 3: Mordwinkin Nicholas Michael, Chief Business Officer No securities owned
10 Dec 2021	Form 3: Wallace Courtney, Director No securities owned
03 Jun 2021	Form 3: Klearman Micki, Director No securities owned
04 May 2020	Form 3: Henig Noreen, Chief Medical Officer No securities owned
06 Feb 2020	Form 3: Equal Talent Investments Ltd, 10% owner Holds 4,800,000 shares of Common Stock
19 Dec 2019	Form 3: Garner Elizabeth, Director No securities owned
06 Mar 2019	Form 3: Economides Vassiliki, SVP, Strategy & External Aff. No securities owned
25 Jun 2018	Form 3: Chiesi Ventures, Inc., 10% owner and 2 others
25 Jun 2018	Form 3: Pappas Arthur M, 10% owner and 4 others
20 Jun 2018	Form 3: Fowler John Franklin, Director Holds 292,704 shares of Common Stock
20 Jun 2018	Form 3: Bay City Capital Llc, 10% owner
20 Jun 2018	Form 3: Steyer Thomas F, 10% owner
20 Jun 2018	Form 3: Onyx Therapeutics, Inc., 10% owner and 1 other
20 Jun 2018	Form 3: Sommadossi Jean-Pierre, Director Holds 90,601 shares of Common Stock
20 Jun 2018	Form 3: Morningside Venture Investments Ltd, 10% owner
20 Jun 2018	Form 3: Omega Fund IV, L.p., 10% owner and 5 others
20 Jun 2018	Form 3: Kirk Christopher J., Director Holds 292,704 shares of Common Stock

Comments